Suvecaltamide pharmacokinetics, safety, & tolerability-Phase 1, randomized, double-blind, multiple ascending dose study

Authors
Category Primary study
Conference10th Congress of the European Academy of Neurology
Year 2024
This article has no abstract
Epistemonikos ID: e2a69d2bf85cef7f5d01863befd5e59c5a645639
First added on: Jan 10, 2026